Celltrion
068270.KS
#812
Rank
โ‚น2.055 T
Marketcap
โ‚น9,443
Share price
-1.13%
Change (1 day)
-8.36%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น255.35. In 2022 the company made an earnings per share (EPS) of โ‚น248.59 a decrease over its 2021 EPS that were of โ‚น295.38.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-1.34%
2022โ‚น248.59-15.84%
2021โ‚น295.3812.77%
2020โ‚น261.9370.79%
2019โ‚น153.3615.63%
2018โ‚น132.63-33.13%
2017โ‚น198.36141.17%
2016โ‚น82.258.28%
2015โ‚น75.9611.28%
2014โ‚น68.2616.37%
2013โ‚น58.66-67.42%
2012โ‚น180.0684.22%
2011โ‚น97.7462.13%
2010โ‚น60.2980.61%
2009โ‚น33.38-559.63%
2008-โ‚น7.26-123.16%
2007โ‚น31.36